IN2012DN01214A - - Google Patents
Info
- Publication number
- IN2012DN01214A IN2012DN01214A IN1214DEN2012A IN2012DN01214A IN 2012DN01214 A IN2012DN01214 A IN 2012DN01214A IN 1214DEN2012 A IN1214DEN2012 A IN 1214DEN2012A IN 2012DN01214 A IN2012DN01214 A IN 2012DN01214A
- Authority
- IN
- India
- Prior art keywords
- jejuni
- antigens
- humans
- animals
- proteijis
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 241000589875 Campylobacter jejuni Species 0.000 abstract 1
- 101100382245 Drosophila melanogaster tsr gene Proteins 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 244000144977 poultry Species 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- G—PHYSICS
- G10—MUSICAL INSTRUMENTS; ACOUSTICS
- G10L—SPEECH ANALYSIS TECHNIQUES OR SPEECH SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING TECHNIQUES; SPEECH OR AUDIO CODING OR DECODING
- G10L13/00—Speech synthesis; Text to speech systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Multimedia (AREA)
- Acoustics & Sound (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Computational Linguistics (AREA)
- Audiology, Speech & Language Pathology (AREA)
- Human Computer Interaction (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Methods and compositions for reducing the incidence of C jejuni bacteria infections, in poultry and in. humans asxi other animals ate formulated to include C. jejuni aatigens, and particularly CadF, FlpA and FkA. The antigens may be provided in the form of polypeptides or by hosts that produce the antigens. Fiferonectin binding proteijis of C jejuni may also be used to deliver substances of interest to humans and other animals.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22625609P | 2009-07-16 | 2009-07-16 | |
PCT/US2010/042262 WO2011009042A2 (en) | 2009-07-16 | 2010-07-16 | Antigen compositions and methods of inhibiting campylobacter jejuni bacterial infection and uses of the antigen compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN01214A true IN2012DN01214A (en) | 2015-04-10 |
Family
ID=43450236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1214DEN2012 IN2012DN01214A (en) | 2009-07-16 | 2010-07-16 |
Country Status (5)
Country | Link |
---|---|
US (1) | US9047864B2 (en) |
EP (1) | EP2453909A4 (en) |
CN (1) | CN102497875B (en) |
IN (1) | IN2012DN01214A (en) |
WO (1) | WO2011009042A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180120136A1 (en) * | 2016-10-27 | 2018-05-03 | General Electric Company | Time-varying flow estimation for virtual flow metering applications |
CN110903359B (en) * | 2019-12-23 | 2021-09-17 | 杭州贤至生物科技有限公司 | Preparation of campylobacter jejuni recombinant protein and monoclonal antibody thereof |
CN112094328A (en) * | 2020-09-21 | 2020-12-18 | 华南农业大学 | Extraction and purification method of Campylobacter jejuni outer membrane vesicles |
CN113144182B (en) * | 2021-04-22 | 2023-03-10 | 成都欧林生物科技股份有限公司 | Helicobacter pylori oral sustained-release vaccine and preparation and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6156546A (en) * | 1997-05-16 | 2000-12-05 | Washington State University Research Foundation | Identification and molecular cloning of a gene encoding a fibronectin binding protein (CadF) from Campylobacter coli and Campylobacter jejuni |
US20050106159A1 (en) | 2003-08-12 | 2005-05-19 | Thompson Stuart A. | Campylobacter jejuni outer membrane protein immunogenic composition |
AU2004291213B2 (en) * | 2003-11-21 | 2011-09-08 | Ace Biosciences A/S | Surface-located campylobacter jejuni polypeptides |
GB0423681D0 (en) | 2004-10-26 | 2004-11-24 | Sec Dep For Environment Food & | Vaccine and nucleic acids |
-
2010
- 2010-07-16 CN CN201080041149.4A patent/CN102497875B/en not_active Expired - Fee Related
- 2010-07-16 EP EP10800604.0A patent/EP2453909A4/en not_active Withdrawn
- 2010-07-16 US US13/384,073 patent/US9047864B2/en not_active Expired - Fee Related
- 2010-07-16 IN IN1214DEN2012 patent/IN2012DN01214A/en unknown
- 2010-07-16 WO PCT/US2010/042262 patent/WO2011009042A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP2453909A4 (en) | 2013-05-01 |
US20120183570A1 (en) | 2012-07-19 |
CN102497875B (en) | 2014-08-20 |
US9047864B2 (en) | 2015-06-02 |
WO2011009042A3 (en) | 2011-05-26 |
WO2011009042A8 (en) | 2012-03-08 |
EP2453909A2 (en) | 2012-05-23 |
WO2011009042A2 (en) | 2011-01-20 |
CN102497875A (en) | 2012-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY162791A (en) | Anti-il-23 antibodies | |
PH12015500092A1 (en) | Compositions for immunising against staphylococcus aureus | |
PH12014501108A1 (en) | Anti-il-36r antibodies | |
EP3054940A4 (en) | Compositions and methods for treating non-alcoholic steatohepatitis | |
EP3296402A3 (en) | Methods and compositions for weed control | |
NZ715201A (en) | Afucosylated anti-fgfr2iiib antibodies | |
PH12015502216A1 (en) | Compositions and methods for improving the health of aquatic animals | |
PH12014502406A1 (en) | Anti-il-23p19 antibodies | |
MX354047B (en) | SPRAY-DRIED <i>LACTOBACILLUS</i> STEMS / CELLS AND THE USE OF SAME AGAINST <i>HELICOBACTER PYLORI. | |
HK1202415A1 (en) | Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15- hetre and methods of use thereof dgla15-ohepa/ 15-hetre | |
WO2012129341A3 (en) | Disease detection in plants | |
MX366368B (en) | Prebiotic oral care methods using a saccharide. | |
AU2011217848A8 (en) | Integrin aVB8 neutralizing antibody | |
MY161601A (en) | Films and compositions comprising the same | |
EP2773317A4 (en) | Compositions for improving the oral health of animals, methods using the same, and pet treats incorporating the same | |
MX2013012136A (en) | Compositions comprising a glucose anti-metabolite and selenium. | |
IN2012DN03404A (en) | ||
MX2016002336A (en) | Formulations for stabilizing moisture in muscle foods. | |
WO2015001013A3 (en) | Human anti-ifn-alpha antibodies | |
IN2012DN01214A (en) | ||
MY173081A (en) | Yeast cell wall components and detection thereof | |
EP2597949A4 (en) | Sub-micron compositions | |
WO2013033092A3 (en) | Streptococcus suis pilus antigens | |
WO2012075104A3 (en) | Novel non-primate hepacivirus | |
AU2015201137B2 (en) | Compositions and method for tissue preservation |